Literature DB >> 12388341

Effect of IL-1beta on CRE-dependent gene expression in human airway smooth muscle cells.

Thomas Lahiri1, Paul E Moore, Simonetta Baraldo, Timothy R Whitehead, Matthew D McKenna, Reynold A Panettieri, Stephanie A Shore.   

Abstract

IL-1beta inhibits isoproterenol (ISO)-induced relaxation of cultured human airway smooth muscle (HASM) cells. The purpose of this study was to determine whether IL-1beta can also suppress ISO-induced cAMP response element (CRE)-dependent gene expression. ISO (10 microM) caused a marked increase in CRE-binding protein (CREB) phosphorylation, which was attenuated by IL-1beta (2 ng/ml). This effect of IL-1beta was abolished by the cyclooxygenase (COX) inhibitor indomethacin. To examine CRE-driven gene expression, we transiently transfected HASM cells with a construct containing CRE upstream of a luciferase reporter gene. ISO (6 h) caused a sixfold increase in luciferase activity. IL-1beta (24 h) alone also increased luciferase activity, although to a lesser extent (2-fold). However, the ability of ISO to elicit luciferase expression was markedly reduced in cells treated with IL-1beta. Indomethacin, the MEK and p38 inhibitors U-0126 and SB-203580, the protein kinase A inhibitor H-89, and dexamethasone each completely abolished the ability of IL-1beta to induce CRE-driven gene expression but only slightly increased the ability of ISO to induce CRE-driven gene expression in IL-1beta-treated cells. IL-1beta also attenuated dibutyryl cAMP-induced CRE-driven gene expression, but not dibutyryl cAMP-induced CREB phosphorylation. Tumor necrosis factor-alpha (10 ng/ml) also attenuated ISO-induced CRE-driven gene expression, even though it was without effect on ISO-induced cAMP formation or ISO-induced CREB phosphorylation. The results suggest that IL-1beta and tumor necrosis factor-alpha may attenuate the ability of beta-agonists to induce expression of genes with CRE in their regulatory regions at least in part through events downstream of CREB phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388341     DOI: 10.1152/ajplung.00231.2001

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  5 in total

1.  Nuclear factor kappa B pathway down-regulates aquaporin 5 in the nasal mucosa of rats with allergic rhinitis.

Authors:  Weiwei Wang; Ming Zheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-21       Impact factor: 2.503

2.  Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.

Authors:  Paola Dazzan; Carmine M Pariante; Valeria Mondelli; Annamaria Cattaneo; Martino Belvederi Murri; Marta Di Forti; Rowena Handley; Nilay Hepgul; Ana Miorelli; Serena Navari; Andrew S Papadopoulos; Katherine J Aitchison; Craig Morgan; Robin M Murray
Journal:  J Clin Psychiatry       Date:  2011-05-18       Impact factor: 4.384

3.  Brain-derived neurotrophic factor induces proliferation of human airway smooth muscle cells.

Authors:  Bharathi Aravamudan; Michael Thompson; Christina Pabelick; Y S Prakash
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

4.  Neurotrophins role in depression neurobiology: a review of basic and clinical evidence.

Authors:  Fani L Neto; Gisela Borges; Sonia Torres-Sanchez; Juan A Mico; Esther Berrocoso
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

5.  Brain-derived neurotrophic factor enhances calcium regulatory mechanisms in human airway smooth muscle.

Authors:  Amard J Abcejo; Venkatachalem Sathish; Dan F Smelter; Bharathi Aravamudan; Michael A Thompson; William R Hartman; Christina M Pabelick; Y S Prakash
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.